Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Comparison of elranatamab's progression-free survival, duration of response, and overall survival from MagnetisMM-3 versus real-world external control arms: A subgroup analysis of China-predominant treatment regimens

Sarasa MA Johnson, Francis Vekeman, Luan Luan, Patrick Hlavacek, Aster Meche, Chai Hyun Kim, Paul Cislo, Didem Aydin, Marco Dibonaventura

Blood (2025) 146 (Supplement 1): 8128.

https://doi.org/10.1182/blood-2025-8128

Published: 2025

Journal Articles

An Indirect Comparison of Elranatamab's Progression-Free Survival, Duration of Response, and Overall Survival from MagnetisMM-3 Versus Real-World External Control Arms in Triple-Class Refractory Multiple Myeloma

Luciano J. Costa, Thomas W. LeBlanc, Hans Tesch, Pieter Sonneveld, Sarasa M.A. Johnson, Francis Vekeman, Patrick Hlavacek, Aster Meche, Paul Cislo, David Hughes, Guido Nador, Marco DiBonaventura

Blood (2024) 144 (Supplement 1): 2401.

https://doi.org/10.1182/blood-2024-203920

Published: 2024